newsfilter
← Latest News
GlobeNewswire·

Myriad Genetics to Present at 2026 Wells Fargo Healthcare Conference

  • Myriad Genetics Inc. (NASDAQ: MYGN) will present at the 21st Annual Wells Fargo Healthcare Conference in Boston on September 10, 2026, at 11:00am EST.
  • The presentation will be accessible via a live audio webcast link in the investor information section of Myriad's website at investor.myriad.com.
  • Myriad Genetics is a molecular diagnostic & precision medicine company that develops tests to assess disease risk, guide treatment decisions, & lower healthcare costs.
  • Investor inquiries can be directed to Matt Scalo at (801) 584-3532 or IR@myriad.com.
  • Media inquiries can be directed to Andria Rosell at (385) 202-3510 or PR@myriad.com.